A Social Science Perspective on Gifts to Physicians from Industry

JAMA

Volumn 290, Issue 2, 2003, Pages 252-255

  Dana, Jason ^a   Loewenstein, George ^a  

^a CARNEGIE MELLON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCOUNTING; DECISION MAKING; DRUG INDUSTRY; ETHICS; HEALTH CARE POLICY; HUMAN; NOTE; PHYSICIAN; POLITICS; PRESCRIPTION; PRIORITY JOURNAL; SOCIOLOGY; ARTICLE; CONFLICT OF INTEREST; EPIDEMIOLOGY; GIFT GIVING; HEALTH CARE AND PUBLIC HEALTH; MANAGEMENT; PERCEPTION; PUBLIC RELATIONS; STANDARD;

HEALTH CARE AND PUBLIC HEALTH;

BIAS (EPIDEMIOLOGY); CONFLICT OF INTEREST; DRUG INDUSTRY; GIFT GIVING; INTERPROFESSIONAL RELATIONS; PHYSICIANS; POLICY MAKING; PRESCRIPTIONS, DRUG; SOCIAL PERCEPTION;

EID: 0038690410     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.290.2.252     Document Type: Note

References (33)

1. Pharmaceutical Research and Manufacturers of America. PhRMA code on interactions with healthcare professionals. Available at: http://www.phrma.org /publications/policy/2002-04-19.391.pdf. Accessibility verified June 12, 2003.
2. Office of Inspector General of Health and Human Services. OIG compliance program guidance for pharmaceutical manufacturers. Available at: http://oig.hhs .gov/fraud/docs/complianceguidance/042803pharmacymfgnonfr.pdf. Accessibility verfied June 12, 2003.
3. Steinman MA, Shlipak MG, McPhee SJ. Of principles and pens: attitudes of medicine housestaff toward pharmaceutical industry promotions. Am J Med. 2001;110:551-557.
4. McKinney W, Schiedermayer D, Lurie N, Simpson D, Goodman J, Rich E. Attitudes of internal medicine faculty and residents toward professional interaction with pharmaceutical sales representatives. JAMA. 1990;264:1693-1697.
5. Hume AL. Doctors, drug companies, and gifts [letter]. JAMA. 1990;263:2177-2178.
6. National Institutes of Health Care Management Research and Educational Foundation. Changing patterns of pharmaceutical innovation. Available at: http://www .nihcm.org/innovations.pdf. Accessibility verified June 12, 2003.
7. Caudill T, Johnson M, Rich E, McKinney P. Physicians, pharmaceutical sales representatives, and the cost of prescribing. Arch Fam Med. 1996;5:201-206.
8. Bower A, Burkett G. Family physicians and generic drugs: a study of recognition, information sources, prescribing attitudes, and practices. J Fam Pract. 1987;24:612-616.
9. Wazana A. Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA. 2000;283:373-380.
10. National Institutes of Health Care Management Research and Educational Foundation. Changing patterns of pharmaceutical innovation. Available at: http://www .nihcm.org/innovations.pdf. Accessibility verified June 12, 2003.
11. Messick DM, Sentis KP. Fairness and preference. J Exp Soc Psychol. 1979;15:418-434.
12. Messick DM, Sentis KP. Fairness, preference, and fairness biases. In: Messick DM, Cook KS, eds. Equity Theory: Psychological and Sociological Perspectives. New York, NY: Praeger; 1983.
13. Loewenstein G, Issacharoff S, Camerer C, Babcock L. Self-serving assessments of fairness and pretrial bargaining. J Leg Stud. 1992;12:135-159.
14. Babcock L, Loewenstein G, Issacharoff S, Camerer C. Biased judgments of fairness in bargaining. Am Econ Rev. 1995;85:1337-1342.
15. Babcock L, Wang X, Loewenstein G. Choosing the wrong pond: social comparisons that reflect a self-serving bias. Q J Econ. 1996;111:1-19.
16. Babcock L, Loewenstein G. Explaining bargaining impasse: the role of self-serving biases. J Econ Perspect. 1997;11:109-126.
17. Babcock L, Loewenstein G, Issacharoff S. Creating convergence: debiasing biased litigants. Law Soc Inquiry. 1997;22:401-413.
18. Caudill T, Johnson M, Rich E, McKinney P. Physicians, pharmaceutical sales representatives, and the cost of prescribing. Arch Fam Med. 1996;5:201-206.
19. Orlowski J, Wateska L. The effects of pharmaceutical firm enticements on physician prescribing patterns. Chest. 1992;102:270-273.
20. Lurie N, Rich E, Simpson D, et al. Pharmaceutical representatives in academic medical centers: interaction with faculty and housestaff. J Gen Intern Med. 1990;5:240-243.
21. Gibbons RV, Landry FJ, Blouch DL, Jones DL, Williams FK, Lucey CR. A comparison of physicians' and patients' attitudes toward pharmaceutical industry gifts. J Gen Intern Med. 1998;13:151-154.
22. Avorn J, Chen M, Hartley R. Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med. 1982;73:4-8.
23. Lexchin J. Interactions between physicians and the pharamaceutical industry: what does the literature say? CMAJ. 1993;149:1401-1406.
24. Spingarn R, Berlin J, Strom B. When pharmaceutical manufacturers' employees present grand rounds, what do residents remember? Acad Med. 1996;71:86-88.
25. McKinney W, Schiedermayer D, Lurie N, Simpson D, Goodman J, Rich E. Attitudes of internal medicine faculty and residents toward professional interaction with pharmaceutical sales representatives. JAMA. 1990;264:1693-1697.
26. Steinman MA, Shlipak MG, McPhee SJ. Of principles and pens: attitudes of medicine housestaff toward pharmaceutical industry promotions. Am J Med. 2001;110:551-557.
27. Palmisano P, Edelstein J. Teaching drug promotion abuses to health profession students. J Med Educ. 1980;55:453-455.
28. Orlowski J, Wateska L. The effects of pharmaceutical firm enticements on physician prescribing patterns. Chest. 1992;102:270-273.
29. Gibbons RV, Landry FJ, Blouch DL, Jones DL, Williams FK, Lucey CR. A comparison of physicians' and patients' attitudes toward pharmaceutical industry gifts. J Gen Intern Med. 1998;13:151-154.
30. Cain D, Moore D, Loewenstein G. The Dirt on Coming Clean: Perverse Effects of Disclosing Conflicts of Interest [working paper]. Pittsburgh, Pa: Graduate School of Industrial Administration, Carnegie Mellon University; 2003.
31. American Medical Student Association. AMSA policy on pharmaceutical promotions. Available at: https://www.amsa.org/prof/policy.cfm.
32. Randall T. Ethics of receiving gifts considered. JAMA. 1991;265:442-443.
33. Pharmaceutical Research and Manufacturers of America. PhRMA code on interactions with healthcare professionals. Available at: http://www.phrma.org /publications/policy/2002-04-19.391.pdf. and http://oig.hhs.gov/fraud/docs /complianceguidance/042803pharmacymfgnonfr.pdf. Accessibility verfied June 12, 2003.